Anatomy & Physiology Study Guide
3

Cell Structure and Genetic Control of Cell Function

Chapter 3Levels of Organization6 h5 sections, outcomes 1-31Week 1 and Week 2

Slide deck, 33 slidesFlashcards, 85Practice questions, 81 in the bank

3.1

Plasma Membrane Structure

1 hWednesday, Nov 18, Week 1

Outcomes

  1. 1Describe the fluid mosaic model, including lipid composition, leaflet asymmetry and the role of cholesterol in membrane fluidity.
  2. 2Distinguish integral, peripheral and lipid-anchored membrane proteins and give one function class for each.
  3. 3Predict which substances cross a phospholipid bilayer unaided based on size, polarity and charge.
  4. 4Explain how glycocalyx carbohydrates and phosphatidylserine asymmetry serve cell recognition and signaling.
  5. 5Relate defects in membrane-associated proteins to hereditary spherocytosis, cystic fibrosis and Duchenne muscular dystrophy.

Outline

  1. A

    Bilayer structure and composition

    1. Phospholipid bilayer about 7-10 nm thick spot-check; hydrophilic heads outward, hydrophobic tails inward; lipids and proteins move laterally (fluid mosaic).
    2. Main lipids: phosphatidylcholine and sphingomyelin (outer leaflet), phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol (inner leaflet); glycolipids exclusively on the extracellular face.
    3. Cholesterol intercalates between tails: stiffens fluid membranes at 37 degrees C and prevents tight packing at low temperature, buffering fluidity.
    4. Lipid rafts are cholesterol/sphingolipid microdomains concentrating signaling proteins; flippases maintain asymmetry using ATP.
  2. B

    Membrane proteins

    1. Integral (transmembrane, usually alpha-helical): channels, carriers, pumps, receptors such as GPCRs; peripheral: attach by electrostatic or protein interactions (ankyrin, spectrin); lipid-anchored (GPI, prenyl or acyl).
    2. Functions: transport, receptor, enzyme, cell adhesion, cytoskeletal anchoring, recognition markers; proteins make up about half the membrane by mass spot-check.
    3. Membrane-cytoskeleton link: spectrin-ankyrin network keeps red cell shape; ankyrin or spectrin mutation causes hereditary spherocytosis.
    4. Dystrophin links actin to the membrane glycoprotein complex in muscle; its loss causes Duchenne dystrophy.
    5. CFTR is an ATP-gated Cl- channel; delta F508 misfolding prevents surface delivery.
  3. C

    Permeability and recognition

    1. Free passage: small nonpolar (O2, CO2, N2), lipid-soluble hormones and drugs, small uncharged polar molecules (water slowly, urea) ; blocked: ions and large or charged polar molecules.
    2. Hence channels, carriers and pumps; mechanisms of transport, gradients and membrane potential are covered in chapter 4.
    3. Glycocalyx: carbohydrate chains on glycoproteins and glycolipids that mediate cell adhesion and ABO antigens.
    4. Phosphatidylserine exposed on the outer leaflet signals apoptosis ('eat-me' signal) and supports coagulation on activated platelets.
  4. D

    Receptor classes (preview)

    1. Ligand-gated ion channels, G protein-coupled receptors, enzyme-linked (receptor tyrosine kinase) receptors, intracellular steroid receptors.
    2. Detailed signal transduction appears with the endocrine chapters; membrane transport and potentials are in chapter 4.

Lab

  • Draw a labeled plasma membrane section showing both leaflets, cholesterol, an integral protein, a peripheral protein, a glycoprotein and a glycolipid.
  • Classify twelve substances (O2, glucose, Na+, steroid hormone, ethanol, urea, protein, etc.) as able or unable to diffuse across the bilayer and justify each.
3.2

Cytoplasm, Organelles, and Cytoskeleton

1.5 hThursday, Nov 19, Week 1

Outcomes

  1. 6Describe the composition and ionic makeup of cytosol and its distinction from extracellular fluid.
  2. 7Identify each membranous organelle by structure and function and link it to one disease of dysfunction.
  3. 8Trace the secretory pathway from ribosome to plasma membrane and name the transport vesicle types.
  4. 9Explain how signal sequences direct proteins to the ER, nucleus, mitochondria, lysosomes and the secretory pathway.
  5. 10Compare microfilaments, intermediate filaments and microtubules by subunit, diameter and function.
  6. 11Explain how kinesin and dynein move cargo and how microtubule defects cause disease.
  7. 12Describe the structure of cilia and centrioles and the effects of primary ciliary dyskinesia.

Outline

  1. A

    Cytosol and inclusions

    1. Cytosol: about 70-80% water plus proteins, enzymes, glycolysis, ribosomes; high K+ (about 140 mM) and low Na+ (about 10-15 mM) and free Ca2+ (about 100 nM) relative to extracellular fluid; pH about 7.2 spot-check.
    2. Inclusions: glycogen granules, lipid droplets, lipofuscin (wear-and-tear pigment), melanin, hemosiderin.
    3. Proteasome and ubiquitin tag clear misfolded or short-lived proteins; autophagy clears organelles and aggregates.
  2. B

    ER, ribosomes and Golgi

    1. Ribosomes: eukaryotic 80S (60S + 40S); free ribosomes make cytosolic proteins, ER-bound make secretory, membrane and lysosomal proteins; mitochondrial ribosomes are 70S.
    2. Rough ER: signal recognition particle halts translation, docks at translocon; N-glycosylation, disulfide bond formation, chaperones (BiP), and the unfolded protein response; abundant in plasma cells and pancreatic acinar cells.
    3. Smooth ER: phospholipid and steroid synthesis, cytochrome P450 drug detoxification, hepatic glucose-6-phosphatase, Ca2+ storage (sarcoplasmic reticulum in muscle).
    4. Golgi: cis (receives), medial and trans faces; sorts, glycosylates and packages; adds mannose-6-phosphate to lysosomal enzymes; trans-Golgi network targets vesicles.
    5. Vesicle coats: COPII ER-to-Golgi, COPI retrograde, clathrin from trans-Golgi and plasma membrane.
  3. C

    Lysosomes, peroxisomes and mitochondria

    1. Lysosomes: pH about 4.5-5, acid hydrolases, degrade phagocytosed material and organelles; storage diseases include Tay-Sachs (hexosaminidase A), Gaucher (glucocerebrosidase), Pompe (acid alpha-glucosidase).
    2. I-cell disease: failure to add mannose-6-phosphate sends lysosomal enzymes out of the cell, with inclusion bodies and skeletal and developmental defects.
    3. Peroxisomes: beta-oxidation of very-long-chain fatty acids, plasmalogen synthesis, H2O2 handled by catalase; Zellweger syndrome (PEX gene defects) and X-linked adrenoleukodystrophy.
    4. Mitochondria: double membrane, cristae in the inner membrane carrying ETC complexes I-IV and ATP synthase, matrix with Krebs cycle and fatty-acid oxidation; intermembrane space holds cytochrome c.
    5. Mitochondrial DNA: circular, about 16.5 kb, 37 genes (13 proteins, 22 tRNAs, 2 rRNAs), maternal inheritance, heteroplasmy; MELAS and LHON are mtDNA diseases spot-check.
    6. Mitochondria take part in apoptosis (cytochrome c release), calcium buffering and heat production (UCP1 in brown fat).
  4. D

    Protein trafficking

    1. N-terminal signal peptide directs translating ribosomes to the ER; ER proteins carry KDEL for retrieval; default route ER -> Golgi -> plasma membrane or secretion.
    2. Nuclear localization signals are bound by importin; mitochondrial presequences are imported through TOM and TIM complexes; peroxisomal PTS1.
    3. Constitutive secretion is continuous; regulated secretion stores vesicles awaiting a Ca2+ signal (insulin, neurotransmitters).
  5. E

    Cytoskeleton, cilia and centrioles

    1. Microfilaments: actin, about 7 nm; cortex, microvilli, contraction, cytokinesis, motility; myosin motors.
    2. Intermediate filaments: 8-12 nm, tissue-specific (keratin, vimentin, desmin, GFAP, neurofilaments, nuclear lamins); mechanical strength; epidermolysis bullosa simplex is a keratin defect.
    3. Microtubules: alpha/beta tubulin heterodimers, about 25 nm hollow, with plus and minus ends; kinesin walks toward the plus end (anterograde in axons) and dynein toward the minus end (retrograde).
    4. Centrosome: two centrioles (nine triplets) organize the spindle; cilia and flagella: 9 + 2 axoneme with dynein arms; primary ciliary dyskinesia (Kartagener syndrome: sinusitis, bronchiectasis, situs inversus, infertility).
    5. Drugs: colchicine and vincristine block microtubule assembly, paclitaxel stabilizes microtubules, preventing mitosis.

Lab

  • Histology Guide MH-009 Golgi apparatus: locate the juxtanuclear Golgi in a secretory cell.
  • Histology Guide MH-010 mitochondria: identify mitochondria and cristae in the electron micrograph set.
  • Histology Guide MH-002 Cells and Tissues: identify basophilic cytoplasm (rough ER) versus eosinophilic cytoplasm (mitochondria, SER) in two cell types.
  • R&P chapter 2 electron micrographs: identify rough ER, smooth ER, Golgi, lysosome, peroxisome, mitochondrion, microtubule bundle and centriole from the ultrastructure alone.
  • Diagram the secretory pathway for insulin from signal peptide to granule exocytosis, naming each compartment and vesicle coat.
3.3

Nucleus, Chromatin, and DNA Replication

1 hThursday, Nov 19, Week 1

Outcomes

  1. 13Describe the nuclear envelope, nuclear pores and nuclear lamina and how nucleocytoplasmic transport works.
  2. 14Explain how DNA is packaged into nucleosomes, chromatin and chromosomes and relate eu- and heterochromatin to transcriptional activity.
  3. 15Explain how DNA methylation and histone modification regulate gene expression and X-inactivation.
  4. 16Describe the steps and enzymes of semiconservative DNA replication, including leading and lagging strand synthesis.
  5. 17Compare the DNA repair pathways and relate each to a hereditary cancer or disease syndrome.
  6. 18Explain how telomeres and telomerase relate to cell aging and cancer.

Outline

  1. A

    Nuclear structure

    1. Double membrane continuous with rough ER; nuclear pores (nuclear pore complexes, about 120 MDa) allow passage of molecules under about 40 kDa freely; larger cargo needs importin/exportin and a Ran-GTP gradient.
    2. Nuclear lamina (lamins A, B, C) under the inner membrane; LMNA mutations cause laminopathies including Hutchinson-Gilford progeria.
    3. Nucleolus: nonmembranous site of rRNA transcription (RNA polymerase I) and ribosomal subunit assembly; prominent in cells making much protein.
    4. Histology: nucleus shows basophilic chromatin; large pale euchromatic nuclei with a prominent nucleolus indicate active cells, small dark nuclei inactive cells.
  2. B

    Chromatin organization

    1. Nucleosome: about 147 bp of DNA wound around an octamer of histones H2A, H2B, H3, H4 (two each); histone H1 binds linker DNA; beads-on-string -> 30-nm fiber -> loops -> metaphase chromosome.
    2. Haploid human genome about 3.2 billion bp; each diploid cell holds about 2 m of DNA in a nucleus of about 6 micrometers diameter spot-check.
    3. Euchromatin is open and transcribed; heterochromatin is condensed and silent; Barr body is the inactivated X in female cells.
    4. Histone acetylation (HATs) opens chromatin; deacetylation (HDACs) and methylation of CpG islands silence genes; epigenetic marks are copied at replication and altered in cancer and imprinting.
  3. C

    DNA replication

    1. Semiconservative; bidirectional from many origins in S phase; helicase unwinds, single-strand binding protein stabilizes, topoisomerase relieves supercoils (target of quinolones in bacteria, etoposide and irinotecan in humans).
    2. Primase makes RNA primers; DNA polymerases delta and epsilon extend 5' -> 3' (leading strand continuous, lagging strand as Okazaki fragments of about 100-200 nt); primers removed and gaps sealed by DNA ligase.
    3. Proofreading by 3' -> 5' exonuclease plus mismatch repair gives an error rate near 1 in 1e9-1e10 bases spot-check.
    4. Telomeres (TTAGGG repeats) solve the end-replication problem; telomerase (RNA template plus reverse transcriptase) is active in germ and stem cells and in most cancers; telomere shortening limits somatic divisions (Hayflick limit).
  4. D

    DNA damage and repair

    1. Base excision repair for oxidized/deaminated bases; nucleotide excision repair for UV thymine dimers (defective in xeroderma pigmentosum); mismatch repair (MSH2, MLH1; defective in Lynch syndrome).
    2. Double-strand breaks: homologous recombination (BRCA1/BRCA2) and nonhomologous end joining; BRCA loss raises breast and ovarian cancer risk.
    3. Damage triggers ATM/ATR kinases -> p53 -> arrest or apoptosis (Section 3.5).

Lab

  • Histology Guide MH-001 Nuclear morphology: distinguish euchromatic from heterochromatic nuclei, find a nucleolus and a Barr body or drumstick where present.
  • Histology Guide MH-012 Nucleic acids: identify DNA and RNA by staining (Feulgen and pyronin or methyl green-pyronin).
  • Diagram a replication fork labeling helicase, primase, leading and lagging strands, Okazaki fragments, ligase and topoisomerase.
  • Match six DNA repair defects to repair pathway and clinical syndrome.
3.4

Gene Expression: Transcription and Translation

1.5 hMonday, Nov 23, Week 2

Outcomes

  1. 19Describe the steps of transcription by RNA polymerase II, including promoter recognition, initiation, elongation and termination.
  2. 20Explain 5' capping, splicing, polyadenylation and alternative splicing in mRNA processing.
  3. 21Use the genetic code to translate an mRNA and classify point mutations as silent, missense, nonsense or frameshift.
  4. 22Describe the roles of mRNA, tRNA and the ribosome A, P and E sites in initiation, elongation and termination of translation.
  5. 23Explain how transcription factors, steroid receptors and non-coding RNAs regulate gene expression.
  6. 24Relate antibiotics, diphtheria toxin and alpha-amanitin to the specific step of gene expression they block.

Outline

  1. A

    Transcription

    1. Template (antisense) strand read 3' -> 5', RNA made 5' -> 3'; RNA polymerase II transcribes mRNA, snRNA and miRNA, Pol I makes rRNA, Pol III makes tRNA and 5S rRNA.
    2. Promoter region (TATA box about 25-30 bp upstream, GC and CAAT boxes) and enhancers bound by general transcription factors (TFIID) and gene-specific activators; Mediator links them to Pol II.
    3. Stages: initiation (pre-initiation complex), promoter escape, elongation, termination via polyadenylation signal; alpha-amanitin (death-cap mushroom) inhibits Pol II.
  2. B

    mRNA processing

    1. 5' 7-methylguanosine cap protects and promotes ribosome binding; 3' poly-A tail (about 200 A, after AAUAAA signal) stabilizes the message.
    2. Introns (GU...AG) removed by the spliceosome (snRNPs); exons joined; autoantibodies to snRNPs occur in lupus (anti-Smith).
    3. Alternative splicing allows one gene to give several proteins; most human multi-exon genes are alternatively spliced spot-check; splice-site mutations cause beta-thalassemia.
  3. C

    Genetic code and translation

    1. 64 codons: 61 sense and 3 stop (UAA, UAG, UGA); start AUG (Met); code is nearly universal, degenerate and nonoverlapping; wobble at the third base.
    2. Aminoacyl-tRNA synthetases charge tRNA; ribosome sites A (aminoacyl-tRNA), P (peptidyl-tRNA), E (exit); peptidyl transferase activity is in rRNA (a ribozyme).
    3. Initiation: small subunit binds cap, scans to AUG, large subunit joins (eIFs, GTP); elongation: eEF1 delivers tRNA, peptide bond forms, eEF2 translocates; termination: release factor recognizes stop codon.
    4. Polysomes allow many ribosomes per mRNA; post-translational modification (cleavage, glycosylation, phosphorylation) and folding follow.
    5. Blockers: aminoglycosides, tetracyclines, macrolides (bacterial 70S ribosome), diphtheria toxin (ADP-ribosylates eEF2), cycloheximide (eukaryotic).
  4. D

    Mutations

    1. Silent (same amino acid), missense (e.g., GAG -> GUG, Glu -> Val in sickle hemoglobin), nonsense (premature stop), frameshift (indel not a multiple of three), splice-site, trinucleotide expansion (Huntington CAG, fragile X CGG).
    2. Germline mutations are inherited; somatic mutations drive cancer; most DNA lesions are repaired before being fixed as mutations.
  5. E

    Regulation of gene expression

    1. Transcription factors act with activators, repressors and enhancers; lipid-soluble hormone receptors (cortisol, thyroid, estrogen) are ligand-activated transcription factors binding hormone response elements.
    2. miRNA and siRNA bind mRNA via RISC to block translation or trigger degradation; chromatin state and DNA methylation regulate access.
    3. Genes can be expressed differently across cell types despite identical DNA; protein half-life is controlled by ubiquitin-proteasome degradation.

Lab

  • Transcribe and translate three DNA sequences using a codon table, then classify the effect of a point mutation introduced in each.
  • Draw the processing of a pre-mRNA with 3 exons: cap, splicing, poly-A, and show an alternative splicing product.
  • Draw a ribosome with A, P and E sites and show the antibiotic action sites.
  • Match six drugs or toxins to the step they block.
3.5

Cell Cycle, Mitosis, Meiosis, and Cell Death

1 hMonday, Nov 23, Week 2

Outcomes

  1. 25Sequence the phases of the cell cycle and describe what happens in each, with typical durations.
  2. 26Explain how cyclin-CDK complexes, Rb, p53 and the spindle assembly checkpoint control progression of the cell cycle.
  3. 27Identify the stages of mitosis and cytokinesis and the chromosome state in each.
  4. 28Compare meiosis I and II with mitosis, including crossing over, independent assortment and the ploidy at each stage.
  5. 29Relate nondisjunction to trisomy 21, Klinefelter and Turner syndromes.
  6. 30Compare apoptosis with necrosis by trigger, morphology, mechanism and inflammatory consequence.
  7. 31Describe how oncogene activation, tumor suppressor loss and failed apoptosis contribute to cancer.

Outline

  1. A

    Cell cycle and control

    1. Interphase (G1, S, G2) then M phase; G0 is a quiescent state; a rapidly dividing human cell takes about 24 h with M about 1 h spot-check.
    2. G1/S: cyclin D-CDK4/6 phosphorylates Rb, releasing E2F; cyclin E-CDK2 commits the cell to S phase; G2/M: cyclin B-CDK1 (MPF) triggers mitosis.
    3. Checkpoints: G1/S (DNA damage via ATM -> p53 -> p21 inhibits CDK), G2/M (DNA replication complete), spindle assembly checkpoint (APC/C activation blocked until all kinetochores attach).
    4. Tissues: labile (epithelia, marrow) divide continuously; stable (hepatocytes) re-enter from G0 on injury; permanent (neurons, cardiomyocytes) do not divide.
  2. B

    Mitosis

    1. Prophase: chromosomes condense (each of two sister chromatids joined at the centromere), centrosomes separate; prometaphase: nuclear envelope breaks down, spindle microtubules bind kinetochores.
    2. Metaphase: chromosomes align at the equator; anaphase: separase cleaves cohesin and sister chromatids move to poles; telophase: nuclei reform and chromosomes decondense.
    3. Cytokinesis: actin-myosin contractile ring creates the cleavage furrow, partly overlapping telophase; midbody abscission.
    4. Result: two diploid (2n, 46 chromosomes) genetically identical daughter cells.
  3. C

    Meiosis

    1. Meiosis I (reductional): homologs synapse in prophase I, cross over at chiasmata (recombination), segregate -> two haploid cells with duplicated chromosomes; meiosis II (equational): sister chromatids separate, like mitosis.
    2. Genetic diversity: independent assortment (2^23, about 8.4 million combinations) plus crossing over.
    3. Spermatogenesis is continuous from puberty and yields four sperm; oogenesis arrests in prophase I from fetal life, resumes at ovulation and arrests at metaphase II until fertilization, producing one ovum and polar bodies.
    4. Nondisjunction yields aneuploidy: trisomy 21 (risk rises with maternal age), 47,XXY Klinefelter, 45,X Turner.
  4. D

    Cell death: apoptosis versus necrosis

    1. Apoptosis is regulated and energy-dependent; intrinsic path: DNA damage or growth-factor loss -> BAX/BAK pores, cytochrome c release -> apoptosome (Apaf-1) -> caspase-9 -> executioner caspases 3 and 7; Bcl-2 and Bcl-xL oppose.
    2. Extrinsic path: Fas ligand or TNF binds death receptor -> FADD -> caspase-8; cytotoxic T cells use perforin and granzyme B.
    3. Morphology: cell shrinkage, chromatin condensation, DNA laddering, membrane blebbing, apoptotic bodies, phosphatidylserine exposure, phagocytosis without inflammation; used in development (digit separation) and tissue homeostasis.
    4. Necrosis is unregulated: ATP depletion or injury -> swelling, membrane rupture, enzyme leakage and inflammation; patterns include coagulative (infarct), liquefactive (brain, abscess), caseous (TB), fat and fibrinoid; necroptosis and pyroptosis are regulated necrotic-like forms.
  5. E

    Clinical: cancer and differentiation

    1. Proto-oncogene gain of function (RAS, MYC) plus tumor suppressor loss (p53, Rb, BRCA) and evasion of apoptosis (BCL2 translocation t(14;18) in follicular lymphoma) drive cancer.
    2. t(9;22) Philadelphia chromosome creates BCR-ABL fusion tyrosine kinase in CML, treated with imatinib.
    3. Stem cells: totipotent, pluripotent, multipotent; differentiation results from selective gene expression, and cell identity is held by epigenetic marks.

Lab

  • Histology Guide MH-015 Mitosis: identify prophase, metaphase, anaphase and telophase cells in the slide.
  • Histology Guide MHS-400 Mitosis: count mitotic figures per high-power field and compute a mitotic index for the section.
  • Draw a pathway diagram of intrinsic and extrinsic apoptosis, marking Bcl-2, cytochrome c, caspases 8, 9 and 3.
  • Compare a micrograph of apoptotic and necrotic cells and list the features that distinguish them.
  • Draw a karyotype diagram showing nondisjunction in meiosis I versus II and the resulting gametes.

Teach-back prompts

  1. Follow a secreted protein from its gene to the extracellular space, naming each organelle, signal and vesicle coat on the way, and say where a defect would cause I-cell disease.
  2. Explain how replication copies DNA with high fidelity and how a defect in each repair system leads to a named cancer syndrome.
  3. Walk through the cell cycle control machinery, from growth factor to cyclin-CDK to Rb to S phase, and show where p53 stops the cycle.
  4. Compare apoptosis and necrosis in a pair of cells and explain why one provokes inflammation and the other does not.

Practical targets

  • Nucleus with nucleolus and euchromatin (Histology Guide MH-001)
  • Golgi apparatus (Histology Guide MH-009)
  • Mitochondria with cristae (Histology Guide MH-010)
  • Rough ER as basophilic cytoplasm (Histology Guide MH-002)
  • Plasma membrane with glycocalyx on an EM (R&P chapter 2)
  • Lysosome and peroxisome on an EM (R&P chapter 2)
  • Centrioles in cross section (R&P chapter 2)
  • Cilia 9+2 axoneme cross section
  • Barr body in a female nucleus
  • Prophase cell (Histology Guide MH-015)
  • Metaphase cell (Histology Guide MH-015)
  • Anaphase cell (Histology Guide MH-015)
  • Telophase cell (Histology Guide MH-015)
  • Apoptotic cell with condensed nucleus versus necrotic cell
  • Replication fork diagram with enzymes labeled
  • Ribosome with A, P and E sites
  • Codon table translation of a short mRNA

Also see